Optimizing Microbial Air Sampling To Reduce False Positives In Cleanrooms

In controlled environments, ensuring sterility is vital. A key process in this setting is microbial air sampling, which helps identify airborne contaminants that could compromise sterile manufacturing. However, a major challenge in this process is the occurrence of false positives, which can trigger unnecessary investigations, production delays, and potential product losses—posing a significant expense for industries like pharmaceuticals, biotechnology, and healthcare.

Learn how modern advancements, such as the BioCapt® Single-Use microbial impactor, can improve the efficiency of microbial air sampling while minimizing the chances of false positives in cleanrooms.